Similarly, stratification by baseline patient risk showed a more pronounced benefit in high-risk patients (RR: 0.47, 95% CI: 0.30–0.75) compared to average-risk individuals (RR: 0.66, 95% CI: 0.52–0.84), though subgroup differences did not reach statistical significance (Q = 2.41, p = 0.121) (online suppl.
← all excerpts
Rectal Indomethacin in Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: An Updated Meta-Analysis with Trial Sequential Analysis.
1
0.1210
0.1210